Navigation Links
Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome
Date:7/22/2014

S is related to its ability to modulate activity in targeted brain regions.

CAUTION: In the United States, eTNS™ is an investigational device and is limited by Federal law to investigational use.  The U.S. Food and Drug Administration (FDA) has given NeuroSigma approval to proceed with a pivotal Phase III clinical trial of eTNS in drug-resistant epilepsy. Completion of that Phase III study is necessary before the FDA will consider permitting the marketing and sale of eTNS in the United States.

eTNS, Monarch, and Monarch eTNS are trademarks of NeuroSigma, Inc.

Research reported in this press release is supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, under Award Number R41-NS076014.  The content is solely the responsibility of NeuroSigma and does not represent the official views of the National Institutes of Health.

About NeuroSigma, Inc.

NeuroSigma is a Los Angeles-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives.  NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD). For more information about NeuroSigma, please visit http://www.neurosigma.com.

Forward-Looking Safe Harbor Statement

This press release contains forward-looking statements, including but not limited to, research and development outcomes, efficacy, adverse reactions, market and product potential, product availability and other statements regarding our eTNS™ system.  These statement
'/>"/>

SOURCE NeuroSigma
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
2. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
3. Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of MST-188
4. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
5. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
6. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
7. AtheroMed Announces Completion of Patient Enrollment in the EASE Study Evaluating the Phoenix Atherectomy System in Treating PAD
8. Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien
9. Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
10. SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
11. Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist Kevin ... recently traveled to Boston, MA ... the 2015 Heart Rhythm Society conference. These scientific ... focus on the ideas, people and technology that ... is a hybrid, minimally invasive cardiac operation that ...
(Date:5/22/2015)... 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a ... and regeneration, today announced that J.J. Finkelstein , ... a corporate overview at two upcoming investor conferences. ... 4 th Annual Microcap Conference on Thursday May ... at 11:00 am EDT.  A webcast will be ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... Feb. 1, 2011 Reportlinker.com announces that a new ... Personalized Medicine - scientific & commercial ... Summary The aim of ... right drug to the right patient and, in some ...
... of Dermatology, Laser and Cosmetics is now offering Alma Lasers ... Boerne area to treat superficial vascular and pigmented irregularities and ... add this new service for our patients," said Dr. Ghohestani, ... a long time provider of aesthetic medicine, we wanted to ...
Cached Medicine Technology:Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 2Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 3San Antonio's Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients 2
(Date:5/24/2015)... Geneva, WI (PRWEB) May 24, 2015 ... Mercy Health System CEO - ... principal and honored at the fourth ... held April 15 at Geneva National ... (by school): ,     -Badger High School, ...
(Date:5/23/2015)... With the implementation of the Affordable Care ... difficult to provide their employees with a viable healthcare ... for employees stand to face strict penalties. Never before ... of a business’s success or failure. In an effort ... Doctors has created a varying level of less expensive ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... The American College of Traditional Chinese Medicine ... will hold a webinar on the updates of the ... Classical Chinese Medicine. , Webinar – First Professional Doctorate ... Dean of Clinical Education, will lead this webinar in ... program. ACTCM is currently developing this degree program based ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at ... the 2015 Congress of Future Medical Leaders in Boston, ... of “America’s highest achieving high school students.” , “I’m ... new goals and learn better study habits,” said Omar. ... which we can ask the surgeons questions.” , The ...
Breaking Medicine News(10 mins):Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2
... French . , Toronto (March 16, 2011) ... received $16 million in funding. The studies, co-funded by the ... Agency (CSA), were announced today at the University of Toronto ... Jane Aubin, Scientific Director of the Canadian Institutes of Health ...
... WEDNESDAY, March 16 (HealthDay News) -- The brain structure of ... a new study. Some of these differences may be ... are likely to be present from birth, said the team ... in the study of phonetics and are able to distinguish ...
... A research article co-authored by Brenna Anderson, MD, director ... Maternal-Fetal Medicine at Women & Infants Hospital of Rhode ... of the American Journal of Reproductive Immunology . ... on the human immunodeficiency virus (HIV) that took place ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... their health benefits during the recession often had no way ... at risk of financial ruin, according to a new report ... the recession catapulted 9 million more Americans -- or ...
... New York, NY, March 16, 2011An estimated nine million ... a job that was lostbecame uninsured in the last two ... Survey, released today. The survey paints a bleak picture for ... they or their spouse lost a job in the past ...
... HealthDay Reporter , TUESDAY, March 15 (HealthDay News) -- ... blood levels of phosphorous, calcium and parathyroid hormone, to assess ... of research stretching back more than 60 years casts doubt ... found little evidence to support the notion that these "biomarkers" ...
Cached Medicine News:Health News:Important funding for nanomedicine research to improve diagnosis and treatment 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 3Health News:Brains of Phonetics Experts Differ From Those of General Public 2Health News:HIV research included in journal 2Health News:Report: Unemployment Adds 9 Million Uninsured in U.S. 2Health News:Report: Unemployment Adds 9 Million Uninsured in U.S. 3Health News:Report: Unemployment Adds 9 Million Uninsured in U.S. 4Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 2Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 3Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 4Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 5Health News:Study Questions Tests Used to Spot Heart Risks in Kidney Patients 2Health News:Study Questions Tests Used to Spot Heart Risks in Kidney Patients 3
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Hollow Copper Tube with Suction Port 16.5....
Surgical Stainless Steel Adult 16.5....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Medicine Products: